Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nicecal is a nutritional supplement developed and marketed by Med Manor Organics. It is formulated as an oral tablet containing a combination of calcium citrate, cholecalciferol (vitamin D3), magnesium, and zinc. Nicecal is designed to support bone density, musculoskeletal health, and immune function, and is primarily used to manage or prevent calcium and vitamin D3 deficiencies, as well as to reduce the risk of osteoporosis and bone fractures. Calcium citrate provides highly absorbable elemental calcium to maintain bone mass, while cholecalciferol enhances intestinal calcium absorption. Magnesium and zinc serve as essential cofactors that support bone mineralization, muscle contraction, nerve transmission, and immune defense.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Nicecal.